Full name : Travers-Lesage Valentin
First name : Valentin
Mail : Normandie Univ, UNICAEN, Centre d'Etudes et de Recherche sur le Medicament de Normandie (CERMN), Caen
Zip Code :
City :
Country : France
Email :
Phone :
Fax :
Website :
Directory :
Comment
| Title : Rational Design and Evaluation of Rivastigmine-Based Pleiotropic Prodrugs for the Treatment of Alzheimer's Disease - Travers-Lesage_2026_ACS.Chem.Neurosci__ |
| Author(s) : Travers-Lesage V , Since M , Wang A , Davis A , Fayolle D , Bernay B , Modeste F , Nachon F , Brazzalotto X , Crouzier L , Sopkova-de Oliveira Santos J , Maurice T , Dallemagne P , Rochais C |
| Ref : ACS Chem Neurosci , : , 2026 |
| Abstract : |
| PubMedSearch : Travers-Lesage_2026_ACS.Chem.Neurosci__ |
| PubMedID: 41972598 |
| Title : Combining beta(2)-AR agonism with butyrylcholinesterase inhibition, a synergistic neuroprotective action against Alzheimer's disease - Wang_2026_RSC.Med.Chem__ |
| Author(s) : Wang A , Curel T , Claeysen S , Travers-Lesage V , Cadot M , Davis A , Sopkova-de Oliveira Santos J , Modeste F , Brazzolotto X , Nachon F , Dallemagne P , Since M , Rochais C |
| Ref : RSC Med Chem , : , 2026 |
| Abstract : |
| PubMedSearch : Wang_2026_RSC.Med.Chem__ |
| PubMedID: 42416270 |
| Gene_locus related to this paper: human-BCHE |
| Title : Access to novel potent pleiotropic prodrugs, targeting both butyrylcholinesterase and serotonin reuptake, with anti-amnesic activities in Alzheimer's disease model - Travers-Lesage_2026_Eur.J.Med.Chem_307_118670 |
| Author(s) : Travers-Lesage V , Crouzier L , Antonijevic M , Wang A , Toublet FX , Davis A , Modeste F , Brazzolotto X , Nachon F , Since M , Maurice T , Rochais C , Dallemagne P |
| Ref : Eur Journal of Medicinal Chemistry , 307 :118670 , 2026 |
| Abstract : |
| PubMedSearch : Travers-Lesage_2026_Eur.J.Med.Chem_307_118670 |
| PubMedID: 41702369 |
| Title : Advances in prodrug design for Alzheimer's disease: the state of the art - Travers-Lesage_2022_Expert.Opin.Drug.Discov_17_325 |
| Author(s) : Travers-Lesage V , Mignani SM , Dallemagne P , Rochais C |
| Ref : Expert Opin Drug Discov , 17 :325 , 2022 |
| Abstract : |
| PubMedSearch : Travers-Lesage_2022_Expert.Opin.Drug.Discov_17_325 |
| PubMedID: 35089846 |